hematologic malignancies transplantation and cord blood transplantation for adult patients with Single-institute comparative analysis of unrelated bone marrow

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Kinetics of myeloid and lymphocyte recovery and infectious complications after unrelated umbilical cord blood versus HLA‐matched unrelated donor allogeneic transplantation in adults

  2004cited by this paper
• Unrelated cord blood transplantation for adult patients with de novo acute myeloid leukemia.

  2004cited by this paper
• Unrelated cord blood transplantation for adult patients with advanced myelodysplastic syndrome.

  2003cited by this paper
• Coexistent naïve phenotype and higher cycling rate of cord blood T cells as compared to adult peripheral blood.

  2003cited by this paper
• Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation.

  2003cited by this paper
• Cytomegalovirus infection following unrelated cord blood transplantation for adult patients: a single institute experience in Japan

  2003cited by this paper
• Umbilical cord blood for unrelated bone marrow replacement; Asia Bank and Japan cord blood bank network update

  2002cited by this paper
• Improved disease-free-survival after transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical unrelated donors in patients with first chronic phase chronic myeloid leukemia.

  2002cited by this paper
• Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemia.

  2002cited by this paper
• Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival.

  2002cited by this paper
• Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors.

  2001cited by this paper
• Standardized, unrelated donor cord blood transplantation in adults with hematologic malignancies.

  2001cited by this paper
• Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis.

  2001cited by this paper
• Successful allogeneic engraftment of mismatched unrelated cord blood following a nonmyeloablative preparative regimen.

  2001cited by this paper
• Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia.

  2001cited by this paper
• Sustained Expression of CD154 (CD40L) and Proinflammatory Cytokine Production by Alloantigen-Stimulated Umbilical Cord Blood T Cells1

  2000cited by this paper
• Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources.

  2000cited by this paper
• Unrelated donor marrow transplantation for chronic myelogenous leukemia: 9 years' experience of the national marrow donor program.

  2000cited by this paper
• Treatment of advanced myelodysplastic syndrome with a regimen including recombinant human granulocyte colony‐stimulating factor preceding allogeneic bone marrow transplantation

  1999cited by this paper
• Factors associated with outcome after cord blood transplantation in children with acute leukemia. Eurocord-Cord Blood Transplant Group.

  1999cited by this paper
• Umbilical cord blood T lymphocytes are induced to apoptosis after being allo-primed in vitro

  1999cited by this paper
• An in vitro model of allogeneic stimulation of cord blood: induction of Fas independent apoptosis.

  1999cited by this paper
• Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient.

  1998cited by this paper
• Intracellular cytokine profile of cord and adult blood lymphocytes.

  1998cited by this paper
• Outcomes among 562 recipients of placental-blood transplants from unrelated donors.

  1998cited by this paper
• Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia.

  1998cited by this paper
• Recombinant human granulocyte colony‐stimulating factor (G‐CSF) combined conditioning regimen for allogeneic bone marrow transplantation (BMT) in standard‐risk myeloid leukemia

  1998cited by this paper
• Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings.

  1997cited by this paper
• Outcome of cord-blood transplantation from related and unrelated donors

  1997cited by this paper
• Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients.

  1996cited by this paper
• Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease.

  1996cited by this paper
• Characterization of the alloreactivity and anti-leukemia reactivity of cord blood mononuclear cells.

  1995cited by this paper
• Analysis of the alloreactive capacity of human umbilical cord blood: implications for graft-versus-host disease.

  1994cited by this paper
• Progress in the ex vivo expansion of hematopoietic progenitors.

  1994cited by this paper
• Recombinant human glycosylated granulocyte colony-stimulating factor (rhG-CSF)-combined regimen for allogeneic bone marrow transplantation in refractory acute myeloid leukemia.

  1994cited by this paper
• Allogeneic responses of human umbilical cord blood.

  1994cited by this paper
• Proliferative and cytotoxic responses of human cord blood T lymphocytes following allogeneic stimulation.

  1994cited by this paper
• Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program.

  1993cited by this paper
• Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma.

  1990cited by this paper
• Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

  1980cited by this paper
• CLINICAL MANIFESTATIONS OF GRAFT‐VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL‐A-MATCHED SIBLING DONOR,S

  1974cited by this paper

• No citing papers are available for this paper.